Solaris Bio: Advanced AI to design epitope-specific antibodies against hard targets

Our Observations

1. AI companies either scale with compute or don't scale at all
2. Proteins are dynamic structures, but existing data is biased toward static structures
3. Models must optimize underlying biophysics or fail to generalize outside the narrow slice of observed antibody space